Cargando…

Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options

The last three years have seen remarkable progress in comprehending predisposing factors and upgrading our treatment arsenal concerning hepatocellular carcinoma (HCC). Until recently, there were no means to withstand the progression of viral hepatitis-associated liver cirrhosis to HCC. A deeper unde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koulouris, Andreas, Tsagkaris, Christos, Spyrou, Vasiliki, Pappa, Eleni, Troullinou, Aikaterini, Nikolaou, Michail
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128500/ https://www.ncbi.nlm.nih.gov/pubmed/34012929 http://dx.doi.org/10.2147/JHC.S300182

Ejemplares similares

Real Impact of Novel Immunotherapy Drugs in Cancer. The Experience of 10 Last Years
por: Koulouris, Andreas, et al.
Publicado: (2021)

Telemedicine in Care of Sarcoma Patients beyond the COVID-19 Pandemic: Challenges and Opportunities
por: Tsagkaris, Christos, et al.
Publicado: (2023)

Second-Line Treatment Options for Hepatocellular Carcinoma: Current Landscape and Future Direction
por: Pathak, Surabhi, et al.
Publicado: (2021)

Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options
por: Panneerselvam, Sugan, et al.
Publicado: (2023)

Resectable Colorectal Cancer: Current Perceptions on the Correlation of Recurrence Risk, Microbiota and Detection of Genetic Mutations in Liquid Biopsies
por: Koulouris, Andreas, et al.
Publicado: (2021)

Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
por: Trojan, Jörg, et al.
Publicado: (2016)

The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges
por: D’Alessio, Antonio, et al.
Publicado: (2021)

The changing epidemiology of hepatocellular carcinoma in Greece
por: Markakis, George E., et al.
Publicado: (2022)

Resistance to TKIs in EGFR-Mutated Non-Small Cell Lung Cancer: From Mechanisms to New Therapeutic Strategies
por: Koulouris, Andreas, et al.
Publicado: (2022)

Azasteroid Alkylators as Dual Inhibitors of AKT and ERK Signaling for the Treatment of Ovarian Carcinoma
por: Dalezis, Panagiotis, et al.
Publicado: (2020)

Second-line treatment options in hepatocellular carcinoma
por: Marino, Donatella, et al.
Publicado: (2019)

Hepatocellular carcinoma diagnosis and treatment: An overview⋆
por: Colquhoun, Steven D., et al.
Publicado: (2020)

Role of fetuin A in the diagnosis and treatment of joint arthritis
por: Pappa, Eleni, et al.
Publicado: (2017)

The mutational landscape of hepatocellular carcinoma
por: Lee, Ju-Seog
Publicado: (2015)

The fusion landscape of hepatocellular carcinoma
por: Zhu, Chengpei, et al.
Publicado: (2019)

Brazilian Landscape of Hepatocellular Carcinoma
por: Fonseca, Leonardo G., et al.
Publicado: (2023)

The radiation therapy options of intracranial hemangiopericytoma: An overview and update on a rare vascular mesenchymal tumor
por: Ciliberti, Maria Paola, et al.
Publicado: (2018)

Comments on “Plastic accumulation during COVID-19: call for another pandemic; bioplastic a step towards this challenge?” by Neeraj K. Aggarwal (10.1007/s11356-021–17792-w)
por: Tsagkaris, Christos, et al.
Publicado: (2022)

The impact of the COVID-19 pandemic on language deserves more attention: evidence from university students in Greece—a research note
por: Loudovikou, Anna, et al.
Publicado: (2022)

An overview of treatment options for urinary stones
por: Shafi, Hamid, et al.
Publicado: (2016)

Hepatocellular Carcinoma—How to Determine Therapeutic Options
por: Mehta, Neil
Publicado: (2020)

New Therapeutic Options for Advanced Hepatocellular Carcinoma
por: Ma, Yu-Shui, et al.
Publicado: (2020)

Review Article: Immune Landscape and Immunotherapy Options in Cervical Carcinoma
por: Kousar, Kousain, et al.
Publicado: (2022)

The genomic landscape of Mongolian hepatocellular carcinoma
por: Candia, Julián, et al.
Publicado: (2020)

Characterization of metabolic landscape in hepatocellular carcinoma
por: Wu, Jing, et al.
Publicado: (2021)

Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence
por: Rahimi, Robert S., et al.
Publicado: (2015)

Treatment options after sorafenib failure in patients with hepatocellular carcinoma
por: Dika, Imane El, et al.
Publicado: (2017)

Current options and future possibilities for the systemic treatment of hepatocellular carcinoma
por: Raoul, Jean-Luc, et al.
Publicado: (2019)

The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma
por: Zhang, Chunye, et al.
Publicado: (2021)

An Overview of Biomarkers for the Diagnosis of Hepatocellular Carcinoma
por: Abu El Makarem, Mona
Publicado: (2012)

An Overview of the Genomic Characterization of Hepatocellular Carcinoma
por: Yim, Sun Young, et al.
Publicado: (2021)

An overview of mouse models of hepatocellular carcinoma
por: Zheng, Hua-chuan, et al.
Publicado: (2023)

Maternal and Neonatal Characteristics and Outcomes of COVID-19 in Pregnancy: An Overview of Systematic Reviews
por: Papapanou, Michail, et al.
Publicado: (2021)

Sporotrichosis: An Overview and Therapeutic Options
por: Mahajan, Vikram K.
Publicado: (2014)

Tivozanib for hepatocellular carcinoma: not likely a new option
por: Estrade, Florian, et al.
Publicado: (2020)

Phytochemicals as an Alternative or Integrative Option, in Conjunction with Conventional Treatments for Hepatocellular Carcinoma
por: Rodriguez, Sheryl, et al.
Publicado: (2021)

Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options
por: Sas, Zuzanna, et al.
Publicado: (2022)

Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options
por: Pourbaghi, Miles, et al.
Publicado: (2023)

New landscapes and horizons in hepatocellular carcinoma therapy
por: Cervello, Melchiorre, et al.
Publicado: (2020)

Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies
por: Giraud, Julie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_34ekmrdd8fhdnvvnvr2c4e1lv1